Concepedia

Christos Stamatis

CS

Statistics

Publications

5

Citations

242

H-Index

5

Active since

2019

Affiliations

Biochemical Society(Current)

University College London

AstraZeneca (United States)

Christos Stamatis is an author at Biochemical Society specializing in pharmacy, process development, and manufacturing of monoclonal antibodies.

ORCID

Publications per year

2019–2023

5

Publications

5

Autologous CAR T-cell therapies supply chain: challenges and opportunities?

Maria M. Papathanasiou, Christos Stamatis, Matthew Lakelin et al. · Cancer Gene Therapy · 2020 · 92 citations · Full text

, , +9

Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D

Suzanne S. Farid, Max Baron, Christos Stamatis et al. · mAbs · 2020 · 80 citations · Full text

, , +17

Process economics evaluation and optimization of adeno‐associated virus downstream processing

Annabel Lyle, Christos Stamatis, Thomas Linke et al. · Biotechnology and Bioengineering · 2023 · 32 citations · Full text

, , +17

Process economics evaluation of cell‐free synthesis for the commercial manufacture of antibody drug conjugates

Christos Stamatis, Suzanne S. Farid · Biotechnology Journal · 2020 · 21 citations · Full text

, , +17

High throughput process development workflow with advanced decision-support for antibody purification

Christos Stamatis, David Gruber, Richard Turner et al. · Journal of Chromatography A · 2019 · 17 citations · Full text

, , +17

1–5 of 5